Distribution of human CMV-specific memory T cells among the CD8(pos.) subsets defined by CD57, CD27, and CD45 isoforms

European Journal of Immunology

Volumn 29, Issue 9, 1999, Pages 2908-2915

  Kern, Florian ^a,b   Khatamzas, Elham ^a   Surel, Ingolf ^a   Frömmel, Claudia ^a   Reinke, Petra ^b   Waldrop, Shar L ^c   Picker, Louis J ^c   Volk, Hans Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD57; Human cytomegalovirus; Memory T cell

Indexed keywords

CD27 ANTIGEN; CD45 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNITY; IMMUNOSTIMULATION; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033370364     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199909)29:09<2908::AID-IMMU2908>3.0.CO;2-8     Document Type: Article

References (36)

1. Kern, F., Ode-Hakim, S., Vogt, K., Hoflich, C., Reinke, P. and Volk, H. D., The enigma of CD57+ CD28-T cell expansion - anergy or activation? Clin. Exp. Immunol. 1996. 104: 180-184.
2. Bruneel, F., Legendre, C., Chatenoud, L., Bach, J. F. and Kreis, H.,T CD57+ lymphocytosis in kidney transplanted patients. Phenotypic and functional study. Presse Med. 1992. 21: 1985-1986.
3. + T cells. Clin. Exp. Immunol. 1994. 95: 465-471.
4. Legendre, C. M., Yip, G. H., Rodrigues, G. A., Forbes, C. and Guttman, R. D., Characterization of an expanded large granular lymphocyte subset lacking natural killer activity present in renal allograft recipients. Transplantation 1987. 43: 229-234.
5. + cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin. Exp. Immunol. 1993. 94: 297-305.
6. + subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease. J. Infect. Dis. 1988. 177: 1083-1087.
7. Borthwick, N. J., Bofill, M., Gombert, W. M., Akbar, A. N., Medina, E., Sagawa, K., Lipman, M. C., Johnson, M. A. and Janossy, G., Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28-T cells, AIDS 1994. 8: 431-441.
8. + lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum. 1993. 36: 608-612.
9. +) T cells in patients with rheumatoid arthritis. Arthritis Rheum. 1997. 40: 237-248.
10. + T lymphocytes are derived from CD57-precursors by differentiation occurring in late immune responses. Eur. J. Immunol. 1994. 24: 1503-1511.
11. Kern, F., Ode-Hakim, S., Nugel, H., Vogt, K., Volk, H. D. and Reinke, P., Peripheral T cell activation in long-term renal transplant patients: concordant upregulation of adhesion molecules and cytokine gene transcription. J. Am. Soc. Nephrol. 1996. 7: 2476-2482.
12. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997. 89: 3700-3707.
13. +) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines. Eur. J. Immunol. 1994. 24: 2903-2909.
14. + cells in human cytomegalovirus and other viral infections. Scand J. Infect. Dis. (Suppl.) 1995. 99: 69-77.
15. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 1995. 155: 5046-5056.
16. - subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J. Immunol. 1993. 101: 429-437.
17. Hintzen, R. Q., de Jong, R., Lens, S. M. and van Lier, R. A., CD27: marker and mediator of T-cell activation? Immunol. Today 1994. 15: 307-311.
18. - T cell subset contains specialized primed T cells. J. Immunol. 1995. 154: 17-25.
19. Collins, R. H., Jr., Sackler, M., Pitcher, C. J., Waldrop, S. L., Klintmalm, G. B., Jenkins, R. and Picker, L. J., Immune reconstitution with donor-derived memory/ effector T cells after orthotopic liver transplantation. Exp. Hematol. 1997. 25: 147-159.
20. + T cells. J. Exp. Med. 1997. 186: 1407-1418.
21. Kern, F., Docke, W. D., Reinke, P. and Volk, H. D., Discordant expression of LFA-1, VLA-4alpha, VLA-beta 1, CD45RO and CD28 on T-cell subsets: evidence for multiple subsets of 'memory' T cells. Int. Arch. Allergy Immunol. 1994. 104: 17-26.
22. + T cells: effector cells. Int. Immunol. 1998. 10: 1837-1845.
23. Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P., Schneider-Mergener, J., Radbruch, A., Walden, P. and Volk, H. D., T-cell epitope mapping by flow cytometry. Nat. Med. 1998. 4: 975-978.
24. D'Arena, G., Musto, P., Cascavilla, N., Di Giorgio, G., Fusilli, S., Zendoli, F. and Carotenuto, M., Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 1998. 83: 197-203.
25. Wu, C. Y., Demeure, C., Kiniwa, M., Gately, M. and Delespesse, G., IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 1993. 151: 1938-1949.
26. Mackall, C. L. and Gress, R. E., Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 1997. 157: 61-72.
27. Bruggemann, C. A., Cytomegalovirus and latency: an overview, Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1993. 64: 325-333.
28. Toro, A. I. and Ossa, J., PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition? Res. Virol. 1996. 147: 233-238.
29. Koffron, A., Varghese, T., Hummel, M., Van, S., Kaufman, D., Fryer, J., Leventhal, J., Stuart, F. and Abecassis, M., Immunosuppression is not required for reactivation of latent murine cytomegalovirus. Transplant. Proc. 1999. 31: 1395-1396.
30. Docke, W. D., Prosch, S., Fietze, E., Kimel, V., Zuckermann, H., Klug, C., Syrbe, U., Kruger, D. H., von Baehr, R. and Volk, H. D., Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994. 343: 268-269.
31. Weekes, M. P., Wills, M. R., Mynard, K., Carmichael, A. J. and Sissons, J. G., The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 1999. 73: 2099-2108.
32. +) T cells in chronic HIV infection are antigen specific. J. Exp. Med. 1998. 188: 785-790.
33. + subset. J. Immunol. 1995. 154: 6182-6190.
34. + memory T cells with different capacities to induce B cell differentiation. J. Immunol. 1995. 155: 149-162.
35. Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R. and Chisari, F. V., Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996. 4: 25-36.
36. + cell noncytotoxic anti-HIV response. Proc. Natl. Acad. Sci. USA 1999. 96: 1030-1035.